Trial · NCT00453349
Participant flow22
How many started, completed or left each group, period by period.
1 to 20 of 22
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomized | STARTED | Moxifloxacin | 228 | |
| Randomized | STARTED | Levofloxacin Plus Metronidazole | 232 | |
| Randomized | COMPLETED | Moxifloxacin | 203 | |
| Randomized | COMPLETED | Levofloxacin Plus Metronidazole | 209 | |
| Randomized | NOT COMPLETED | Moxifloxacin | 25 | |
| Randomized | NOT COMPLETED | Levofloxacin Plus Metronidazole | 23 | |
| Reaching of Primary Endpoint (TOC) | STARTED | Moxifloxacin | 225 | |
| Reaching of Primary Endpoint (TOC) | STARTED | Levofloxacin Plus Metronidazole | 230 | |
| Reaching of Primary Endpoint (TOC) | Valid for Primary Efficacy Analysis | Moxifloxacin | 194 | |
| Reaching of Primary Endpoint (TOC) | Valid for Primary Efficacy Analysis | Levofloxacin Plus Metronidazole | 190 | |
| Reaching of Primary Endpoint (TOC) | COMPLETED | Moxifloxacin | 215 | |
| Reaching of Primary Endpoint (TOC) | COMPLETED | Levofloxacin Plus Metronidazole | 219 | |
| Reaching of Primary Endpoint (TOC) | NOT COMPLETED | Moxifloxacin | 10 | |
| Reaching of Primary Endpoint (TOC) | NOT COMPLETED | Levofloxacin Plus Metronidazole | 11 | |
| Completed Study | STARTED | Moxifloxacin | 228 | |
| Completed Study | STARTED | Levofloxacin Plus Metronidazole | 232 | |
| Completed Study | Completed Study Treatment | Moxifloxacin | 203 | |
| Completed Study | Completed Study Treatment | Levofloxacin Plus Metronidazole | 209 | |
| Completed Study | COMPLETED | Moxifloxacin | 201 | |
| Completed Study | COMPLETED | Levofloxacin Plus Metronidazole | 198 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00453349/flow